Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 [Seeking Alpha]
Sutro Biopharma, Inc. (STRO)
Last sutro biopharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
STRO's pipeline centers on next-generation ADCs, with lead candidate STRO-004 in Phase 1 and key data expected mid-2026. Strategic partnerships, notably with Astellas, offer milestone potential, but past alliances (Ipsen, BMY, EMD Serono) have lapsed. Despite a $48.5m Q3 loss and $167.5m cash, STRO claims funding into late 2027; clinical validation and partner progress are critical catalysts. Looking for a portfolio of ideas like this one? Members of Haggerston BioHealth get exclusive access to our subscriber-only portfolios. Learn More » Klaus Vedfelt/DigitalVision via Getty Images Investment Overview Sutro Biopharma ( STRO ) stock trades at a value of $25 today, following a 1-10 reverse stock split completed in December 2025. The South San Francisco-based biotech's market cap valuation is $406m at the More on my IG service If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the
Show less
Read more
Impact Snapshot
Event Time:
STRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STRO alerts
High impacting Sutro Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
STRO
News
- Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma to Participate in Upcoming Investor ConferencesGlobeNewswire
- Sutro Biopharma Announces Participation at the 16th World ADC London SummitGlobeNewswire
- Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains? [Yahoo! Finance]Yahoo! Finance
STRO
Earnings
- 5/8/25 - Miss
STRO
Analyst Actions
- 1/20/26 - Citigroup Inc.
STRO
Sec Filings
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- 3/3/26 - Form 4
- STRO's page on the SEC website